2024 update in heart failure

2024 update in heart failure

Abstract In the last years, major progress has occurred in heart failure (HF) management. The 2023 ESC focused update of the 2021 HF guidelines introduced new key recommendations based on the results of the last years of science. First, two drugs, sodium–glucose co‐transporter‐2 (SGLT2) inhibitors a...

Full description

Saved in:
Bibliographic Details
Main Authors: Alberto Beghini, Antonio Maria Sammartino, Zoltán Papp, Stephan vonHaehling, Jan Biegus, Piotr Ponikowski, Marianna Adamo, Luigi Falco, Carlo Mario Lombardi, Matteo Pagnesi, Gianluigi Savarese, Marco Metra, Daniela Tomasoni
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:ESC Heart Failure
Subjects:
comorbidities
finerenone
heart failure
prevention
prognosis
SGLT2 inhibitors
Online Access:https://doi.org/10.1002/ehf2.14857
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ehf2.14857

Similar Items